Viewpoint: Are the U.S. and Europe headed towards a repudiation of agricultural biotechnology red tape?

Screenshot 2026-07-22 at 1.38.55 PM

2026 may well be remembered as the year global agriculture began to untangle itself from decades of precautionary red tape. Earlier this year, the agricultural biotechnology landscape shifted in two places that have long defined opposite poles of the regulatory debate: the European Union, historically the home of exceedingly precautionary biotech rules, and the United States, a pro-innovation leader now eyeing a massive regulatory overhaul.

The EU Parliament recently approved a landmark framework for regulating New Genomic Techniques (NGTs). Many plants developed with CRISPR or other precise gene-editing techniques will now be treated more like conventional crops by regulators than transgenics, commonly referred to as “GMOs.” Meanwhile, the US Department of Agriculture is weighing a clean break from its legacy Part 340 biotechnology rules, in place since the late 1980s.

Together, these moves mark a broader retreat from process-based regulation toward more risk-based and technology-agnostic frameworks. Product-based regulations ask what a product does, what risks it plausibly poses, and whether regulation will actually improve safety—rather than focusing on the technology used in development. This is about more than administrative streamlining; it’s the key to a new wave of agricultural innovation.

Mis- and disinformation are distorting science and public policy. Subscribe to our Daily and Weekly Digests for incisive coverage of ‘disruptive’ innovations in AI, agricultural biotechnology, food, chemicals, nuclear energy, vaccines, and other disruptive innovations.

While the EU’s NGT reforms and the US’s potential overhaul are steps in the right direction, true modernization demands that all genetically engineered products—gene-edited and transgenic alike—be treated the same as conventionally bred crops. Continuing to differentiate between these categories as a proxy for risk conflicts with the scientific consensus that gene-edited and transgenic crops don’t pose new risks compared to conventional breeding, often making changes to a plant’s DNA with greater speed and accuracy and fewer unintended changes. Only by aligning regulations with established science will we unlock the benefits of biotechnology innovation in agriculture.

Emily Bass is Associate Director of Federal Policy, Food and Agriculture at Breakthrough Institute. Follow Emily on X @EmilyJane_Bass

A version of this article was originally posted at The Ecomodernist and has been reposted here with permission. Any reposting should credit the original author and provide links to both the GLP and the original article. Find Breakthrough Institute on X @TheBTI

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-10-07-at-1.03.15-PM
Anti-vaxxers’ double whammy: Exaggerated vaccine fears have fueled measles outbreaks and preventable deaths—and left survivors more vulnerable to other infections for years
Prescription Capsules Scattered on Twenty-Dollar Bills
Facts & Fallacies podcast: America's health care system is broken. A doctor explains how to fix it, Part 2
Crossed-Out-Calendar-with-Milk-Carton
Viewpoint: The shocking consequences after a year of Robert F. Kennedy Jr.'s distortions, deceptions, and flat-out falsehoods
Frosted Blueberries Under Magnification
MAHA moms divided over RFK Jr.’s food‑safety efforts, as recall alerts grow and outbreaks spread
Golden Wheat Under a Starry Sky
Viewpoint: ‘Bureaucratic and economic obstacles’ to agricultural biotechnology: Europe creeps into the 21st century, but blocks remain
Cross and Syringe Standoff
Viewpoint: Hijacking Jesus: How anti-vaccine fanatics are exploiting religious exemptions and killing children
Pride and Patriotism in the Breeze
Retreat from identity labels: Does the sharply declining number of young teens identifying as gay and bisexual reflect an ideological shift?
Screenshot-2026-10-12-at-10.44.38-AM
Widely condemned as unethical, hepatitis B vaccine study funded by RFK Jr’s CDC gets a final greenlight
Screenshot-2026-10-08-at-10.41.33-AM
Viewpoint: Wellness patches: Most vitamin supplements are useless and sometimes even dangerous, but this craze is even worse
Deepfake Democracy Media Mosaic
31 states have passed a patchwork of laws to limit election deepfake commercials. They’re not working very well.
Dissolving-Tablets-in-Waves
Viewpoint: How the anti-abortion movement twists medical facts and promotes science misinformation
MAHA-MOMS-Supporters-at-the-Rally
Viewpoint: How 'MAHA men' hijacked the female-built food and wellness movement
Screenshot-2026-09-22-at-12.26.15-PM
‘Forever chemical’ concerns: Separating hysteria from reasonable concern in the debate over PFAS danger
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.